However, little attention has been placed on the effects of semaglutide or other GLP1-RAs on cannabis consumption even though the prevalence of cannabis use is even higher than that of tobacco use among certain demographics
A 2022 randomized trial of exenatide did not meet its primary endpoint for reducing heavy drinking days in the overall population, though exploratory analyses suggested potential benefits in participants with obesity
doi: 10.1016/j.dsx.2021.102382 89 KristensenSLRrthRJhundPSDochertyKFSattarNPreissDet al
Want to learn more or can't find what you are looking for
While there is some controversy over these calculations, theres no question that people who lose fat are also losing some muscle
reports research grants from Allelica, Amgen, Apple, Boston Scientific, Genentech/Roche and Novartis